Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy

Yulia A. Kandrashkina; Кандрашкина Юлия Андреевна; E. A. Orlova; Орлова Е. А.; O. A. Levashova; Левашова О. А.; E. M. Kostina; Костина Е. М.

doi:10.18565/pharmateca.2024.1.183-187

Filaggrin as a biomarker of exacerbation of atopic dermatitis during pregnancy

Авторлар: Kandrashkina Y.A.¹, Orlova E.A.¹, Levashova O.A.¹, Kostina E.M.¹
Мекемелер:
1. Penza Institute for Advanced Medical Training – Branch Campus of the RMACPE
Шығарылым: Том 31, № 1 (2024)
Беттер: 183-187
Бөлім: Dermatology/allergology
URL: https://journals.eco-vector.com/2073-4034/article/view/632307
DOI: https://doi.org/10.18565/pharmateca.2024.1.183-187
ID: 632307

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация
Толық мәтін
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

Background. Today, there are many experimental studies on the study of mutations of the filaggrin gene (FLG) in atopic dermatitis (AD), determining the FLG level in the skin, but there are very few studies devoted to the study of the blood serum FLG level in this pathology. It is of interest to study the role of FLG in AD during pregnancy.

Objective. Evaluation of the serum FLG level in pregnant women with AD.

Methods. The single-arm, open-label clinical comparative prospective randomized controlled trial included 76 pregnant women with exacerbation of AD, 23 non-pregnant women with exacerbation of AD, 20 pregnant women without AD, and 20 non-pregnant women without AD. The AD severity was determined using the SCORAD index. The blood serum FLG level was determined by enzyme immunoassay.

Results. In pregnant women with exacerbation of AD, the FLG level was statistically significantly higher than in non-pregnant women with AD, pregnant and non-pregnant women without AD (Mann-Whitney test; p < 0.05). There was a moderate statistically significant relationship between the blood serum FLG level and the SCORAD index (R=0.653; p=0.001, direct relationship).

Conclusion. Pregnant women with AD exacerbation have high serum FLG levels, so FLG can be considered as an important biomarker for AD exacerbation during pregnancy. Further in-depth study of the role of FLG in the pathogenesis of AD during pregnancy will contribute to the formation of a more complete picture of the mechanism of development of dermatitis.

Негізгі сөздер

filaggrin, atopic dermatitis, pregnancy, SCORAD index

Толық мәтін

Авторлар туралы

Yulia Kandrashkina

Penza Institute for Advanced Medical Training – Branch Campus of the RMACPE

Хат алмасуға жауапты Автор.
Email: novikova10l@mail.ru
ORCID iD: 0000-0002-5537-5729

Postgraduate Student at the Department of Allergology and Immunology with a Course of Dermatovenereology and Cosmetology

Ресей, Penza

Әдебиет тізімі

Круглова Л.С., Переверзина Н.О. Филаггрин: от истории открытия до применения модуляторов филаггрина в клинической практике (обзор литературы). Медицинский алфавит. 2021;27:8–12. [Kruglova L.S., Pereverzina N.O. Filaggrin: from the history of discovery to the use of filaggrin modulators in clinical practice (literature review). Med Alf. 2021;27:8–12. (In Russ.)]. doi: 10.33667/2078-5631-2021-27-8-12.
Фуникова А. Атопический дерматит. Новые аспекты патогенеза, современные исследования. Критерии постановки диагноза. Косметолог. 2013;1. [Funikova A. Atopic dermatitis. New aspects of pathogenesis, modern research. Criteria for making a diagnosis. Cosmetologist. 2013;1. (In Russ.)].
Kuechle M., Presland R., Lewis S., et al. Inducible expression of filaggrin increases keratinocyte susceptibility to apoptotic cell death. Cell Death Differ. 2000;7(6):566–73. doi: 10.1038/sj.cdd.4400687.
Pearton D.J., Nirunsuksiri W., Rehemtulla A., et al. Proprotein convertase expression and localization in epidermis: Evidence for multiple roles and substrates. Exp Dermatol. 2001; 10(3):193–203. doi: 10.1034/j.1600-0625.2001.010003193.x.
Kuechle M. K., Predd H. M., Fleckman P., et al. Caspase‐14, a keratinocyte specific caspase: MRNA splice variants and expression pattern in embryonic and adult mouse. Cell Death Different. 2001;8(8):868–70. doi: 10.1038/sj.cdd.4400897.
Alef T., Torres S., Hausser I., et al. Ichthyosis, follicular atrophoderma, and hypotrichosis caused by mutations in ST14 is associated with impaired profilaggrin processing. J Investig Dermatol. 2009;129(4):862–69. doi: 10.1038/jid.2008.311.
Kobiela A., Hovhannisyan L., Jurkowska P., et al. Excess filaggrin in keratinocytes is removed by extracellular vesicles to prevent premature death and this mechanism can be hijacked by Staphylococcus aureus in a TLR2-dependent fashion. J Extracell Vesicl. 2023;12(6):e12335. doi: 10.1002/jev2.12335.
Presland R.B., Kuechle M.K., Lewis S.P., et al. Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell‐cell adhesion, and cell cycle arrest. Exp Cell Res. 2001;270(2):199–213. doi: 10.1006/excr.2001.5348.
Rasheed Z., Zedan K., Saif G.B., et al. Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and immunoglobulin E. Clin Mol Allergy. 2018;16:23. doi: 10.1186/s12948-018-0102-y.
Ghada A., Rasheed Z., Salama R.H., et al. Filaggrin, major basic protein and leukotriene B4: Biomarkers for adult patients of bronchial asthma, atopic dermatitis and allergic rhinitis. Intractable Rare Dis Res. 2018;7(4):264–70. doi: 10.5582/irdr.2018.01111.
Передкова Е.В., Себекина О.В. Влияние беременности на течение аллергических заболеваний. Эффективная фармакотерапия. 2019;15(37):18–26. [Peredkova E.V., Sebekina O.V. The influence of pregnancy on the course of allergic diseases. Effekt Farmakoter. 2019;15(37):18–26. (In Russ.)]. doi: 10.33978/2307-3586-2019-15-37-18-26.
Жильцова Е.Е., Чахоян Л.Р. Роль иммунологических нарушений в развитии атопического дерматита. Res Pract Med J. 2018;5(1):45–51. [Zhil’tsova E.E., Chakhoyan L.R. The role of immunological disorders in the development of atopic dermatitis. Res Pract Med J. 2018;5(1):45–51. (In Russ.)].
Клинические рекомендации по атопическому дерматиту. Российская ассоциация аллергологов и клинических иммунологов, союз педиатров России, Национальный альянс дерматовенерологов и косметологов. 2023. 119 с. [Clinical guidelines for atopic dermatitis. Russian Association of Allergists and Clinical Immunologists, Union of Pediatricians of Russia, National Alliance of Dermatovenereologists and Cosmetologists. 2023. 119 p. (In Russ.)].